Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand?

By Liapi Eleni  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1234-1246

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-01 ,pp. : 1081-1087

Bentham Science Publishers

Access to resources Recommend Favorite

Breast Cancer Risk Assessment Models: Where We Stand and Where We Are Going(

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 5-16

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Dissemination research in cancer control: where are we and where should we go?

By Bowen Deborah  

Cancer Causes and Control, Vol. 20, Iss. 4, 2009-05 ,pp. : 473-485

Springer Publishing Company

Access to resources Recommend Favorite

Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

By Katz Matthew  

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 608-610

Springer Publishing Company

Access to resources Recommend Favorite